0000950170-21-002521.txt : 20211029 0000950170-21-002521.hdr.sgml : 20211029 20211029170044 ACCESSION NUMBER: 0000950170-21-002521 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20211027 ITEM INFORMATION: Termination of a Material Definitive Agreement FILED AS OF DATE: 20211029 DATE AS OF CHANGE: 20211029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 211364070 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET STREET 2: FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET STREET 2: FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 8-K 1 acet-20211027.htm 8-K 8-K
false000172058000017205802021-10-272021-10-27

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 27, 2021

 

Adicet Bio, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-38359

81-3305277

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 


 

 

200 Clarendon Street, Floor 6

Boston, MA

02116

 

 

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (650) 503-9095

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

ACET

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 1.02 Termination of a Material Definitive Agreement


As previously disclosed, on September 15, 2020, resTORbio, Inc. (the predecessor of Adicet Bio, Inc., referred to herein as “resTORbio” or the “Company”) entered into a Contingent Value Rights Agreement (the “Rights Agreement”) with Computershare, Inc. and its wholly owned subsidiary, Computershare Trust Company, N.A. (jointly referred to herein as “Computershare”). The CVR Agreement entitled certain holders of resTORbio common stock to receive substantially all of the net proceeds from the commercialization, if any, received from a third party commercial partner of RTB101, a small molecule product candidate, previously developed by resTORbio, for a COVID-19 related indication.

Pursuant to Section 4.2(c) of the Rights Agreement, on October 27, 2021, the Company delivered written notice to Computershare to terminate its obligations under the Rights Agreement, effective as of October 27, 2021. The Company is not subject to any termination penalties related to the termination of the Rights Agreement.

A copy of the Rights Agreement was filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on September 16, 2020. The description of the Rights Agreement contained in this Current Report on Form 8-K does not purport to be complete and is qualified in its entirety by reference to the copy of the Rights Agreement filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on September 16, 2020.


 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ADICET BIO, INC.

 

 

 

 

Date: October 29, 2021

 

By:

/s/ Nick Harvey

 

 

Name:

Nick Harvey

 

 

Title:

Chief Financial Officer

 

 

 EX-101.SCH 2 acet-20211027.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 3 acet-20211027_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 4 acet-20211027_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Health Care Organizations [Abstract] Entity Central Index Key Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period XML 5 acet-20211027_htm.xml IDEA: XBRL DOCUMENT 0001720580 2021-10-27 2021-10-27 false 0001720580 8-K 2021-10-27 Adicet Bio, Inc. DE 001-38359 81-3305277 200 Clarendon Street Floor 6 Boston MA 02116 650 503-9095 false false false false Common Stock, par value $0.0001 per share ACET NASDAQ true false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Oct. 27, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 27, 2021
Entity Registrant Name Adicet Bio, Inc.
Entity Central Index Key 0001720580
Entity Incorporation State Country Code DE
Entity File Number 001-38359
Entity Tax Identification Number 81-3305277
Entity Address, Address Line One 200 Clarendon Street
Entity Address, Address Line Two Floor 6
Entity Address, City or Town Boston
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02116
City Area Code 650
Local Phone Number 503-9095
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.0001 per share
Trading Symbol ACET
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports acet-20211027.htm acet-20211027.xsd acet-20211027_lab.xml acet-20211027_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "acet-20211027.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "acet-20211027.htm" ] }, "labelLink": { "local": [ "acet-20211027_lab.xml" ] }, "presentationLink": { "local": [ "acet-20211027_pre.xml" ] }, "schema": { "local": [ "acet-20211027.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "acet", "nsuri": "http://www.adicetbio.com/20211027", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "acet-20211027.htm", "contextRef": "C_4ac55906-6fd5-49c4-97d1-e3d41a8c5583", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "acet-20211027.htm", "contextRef": "C_4ac55906-6fd5-49c4-97d1-e3d41a8c5583", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.adicetbio.com/20211027/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0000950170-21-002521-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-21-002521-xbrl.zip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end